Skip to content

Retrospective Chart Review of the 5 & 2 & 2 and 4 & 2 & 1 Plans

A Retrospective Chart Review to Assess Weight Loss in Overweight and Obese Adults Using Either the 5 & 2 & 2 Meal Replacement Plan or the 4 & 2 & 1 Meal Replacement Plan at Medifast Weight Control Centers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02150837
Enrollment
372
Registered
2014-05-30
Start date
2014-01-31
Completion date
2014-05-31
Last updated
2019-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, Weight Loss, Meal replacements, Weight maintenance

Brief summary

The purpose of this study is to retrospectively and systematically review records of overweight and obese Medifast Weight Control Center (MWCC) members who have been assigned to the 5 & 2 & 2 Plan or the 4 & 2 & 1 Plan for weight loss to gain a better understanding of the effectiveness of these programs. The study will describe demographics of this population, along with weight loss, anthropometrics, body composition and effects on available cardiovascular parameters. Adherence to the plans will also be examined. The study hypothesis is that the 5 & 2 & 2 Meal Replacement Plan and the 4 & 2 & 1 Meal Replacement Plan are both effective programs for weight loss in overweight and obese adults.

Interventions

OTHER5 & 2 & 2 Plan

Medifast has developed the 5 & 2 & 2 Plan as a higher calorie and higher carbohydrate alternative. This plan may be selected for very obese (BMI ≥ 40kg/m2) or older (\>65 years) individuals, or for medical (e.g., diabetes) or behavioral reasons (individuals engages in high levels of physical activity). The 5 & 2 & 2 Plan consists of 5 Medifast meal replacements, 2 Lean & Green meals, and 2 healthy snacks and provides 1,200-1,400 kcal, \>72g protein, \>100g of carbohydrate, and \<30% of calories from fat. The Lean & Green meal is consumer selected and consists of 5-7 ounces of a lean protein, 1 ½ - 3 cups of non-starchy vegetables, and up to 2 healthy fat servings. The healthy snack(s) included in this plans consists of a consumer selected serving of grain/starch, dairy, or fruit.

OTHER4 & 2 & 1 Plan

Medifast has developed the 4 & 2 & 1 Plan as a higher calorie and higher carbohydrate alternative. This plan may be selected for very obese (BMI ≥ 40kg/m2) or older (\>65 years) individuals, or for medical (e.g., diabetes) or behavioral reasons (individuals engages in high levels of physical activity). The 4 & 2 & 1 Plan consists of 4 Medifast meal replacements, 2 Lean & Green meals, and 1 healthy snack, providing 1,000-1,200 kcal, \>72g protein, \>100g carbohydrate, and \<30% of calories from fat. The Lean & Green meal is consumer selected and consists of 5-7 ounces of a lean protein, 1 ½ - 3 cups of non-starchy vegetables, and up to 2 healthy fat servings. The healthy snack included in this plans consist of a consumer selected serving of grain/starch, dairy, or fruit.

Sponsors

Medifast, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult males and females, 18 years of age or older at the start of the weight loss program. * Subject has a BMI ≥ 25 kg/m2. * Subject started a weight management program at the MWCC location on or after January 1, 2012. * Subject followed the 5 & 2 & 2 Plan or the 4 & 2 & 1 Plan for at least the first two weeks of their weight loss phase while an active member of the MWCC. * Subject signed the Personal Health Information Consent Form.

Exclusion criteria

* Subject was concurrently following another weight loss program other than the 5 & 2 & 2 Plan or the 4 & 2 & 1 Plan while on that respective plan. * Subject had documented use of prescription or over-the-counter weight loss pharmacotherapy (e.g., phentermine, Orlistat) concurrently with the 5 & 2 & 2 Plan or the 4 & 2 & 1 Plan. * Subject completed initial consultation but did not participate in any follow-up visits. * Subject is currently in the active weight loss phase of their program at the MWCC (Subjects in the transition or weight maintenance phases of their programs are eligible.) * Written request by subject to revoke consent to use health information is present in subject chart.

Design outcomes

Primary

MeasureTime frameDescription
Body Weight12 weeksThe primary endpoint in this study is weight and the primary outcome is change from baseline body weight at 12 weeks for each plan (5 & 2 & 2 and 4 & 2 & 1 Plans). Change from baseline will also be examined at other predetermined time points (e.g., 1, 2, 4, 8, 16, 20 and 24 weeks, and final weight loss visit - the mean length of time from baseline to the final weight loss visit was 18.06 weeks for the 5 & 2 & 2 Plan and 17.35 weeks for the 4 & 2 & 1 Plan.).

Secondary

MeasureTime frameDescription
Proportion of Subjects Who Lose at Least 10% of Baseline Body Weight12 weeksThe categorical endpoint of the proportion of subjects who lose at least 10% of baseline body weight while on each program (5 & 2 & 2 and 4 & 2 & 1 Plans).
Lean Mass12 weeksLean mass expressed as an absolute change from baseline.
Fat Mass12 weeksFat mass expressed as an absolute change from baseline.
Abdominal Circumference12 weeksAbdominal circumference expressed as an absolute change from baseline.
Waist Circumference12 weeksWaist circumference expressed as an absolute change from baseline.
Hip Circumference12 weeksHip circumference expressed as an absolute change from baseline.
Percentage of Subjects Who Lose at Least 5% of Baseline Body Weight12 weeksThe categorical endpoint of the proportion of subjects who lose at least 5% of baseline body weight while on each plan (5 & 2 & 2 and 4 & 2 & 1 Plans).
Pulse12 weeksPulse expressed as an absolute change from baseline.
Blood Pressure Categorical12 weeksBlood pressure expressed as a categorical variable (normotensive, pre-hypertensive and hypertensive based on National Institute of Health Guidelines) with the percent of participants that improved (e.g. from hypertensive to pre-hypertensive or normal) their blood pressure category from baseline to 12 weeks.
Resting Metabolic RateBaseline to final weight loss visit (Average of 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan)Resting metabolic rate expressed as an absolute change from baseline to final weight loss visit (The average length of time from baseline to the final weight loss visit was 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan.).
Adherence12 weeksAdherence will be assessed through attendance at weekly visits and documented use of meal replacements at each visit. (Meal replacement adherence=average number of self-reported daily meal replacements through 12 weeks/nuber of prescribed meal replacements; Attendance adherence=number of visits/number of weeks on plan
Proportion of Subjects Who Lose at Least 5% of Baseline Body Weight1 weeksThe categorical endpoint of the proportion of subjects who lose at least 5% of baseline body weight while on each plan (5 & 2 & 2 and 4 & 2 & 1 Plans).
Body Weight1 weekChange in body weight from baseline reported as absolute change.
Blood Pressure12 weeksBlood pressure (systolic and diastolic) expressed as an absolute change from baseline.

Countries

United States

Participant flow

Recruitment details

This is a retrospective chart review of Medifast Weight Control Center (MWCC) clients from 21 centers that used either the Medifast 5 & 2 & 2 Plan or 4 & 2 & 1 Plan for weight loss between 1/2012 and 3/2014 - it is retropsective and observational in nature, so there was no recruitment involved. The plans were evaluated separately and not compared.

Participants by arm

ArmCount
5 & 2 & 2 Plan
MWCC members who used the Medifast 5 & 2 & 2 Meal Replacement Plan for weight loss. 5 & 2 & 2 Plan: Medifast has developed the 5 & 2 & 2 Plan as a higher calorie and higher carbohydrate alternative. This plan may be selected for very obese (BMI ≥ 40kg/m2) or older (\>65 years) individuals, or for medical (e.g., diabetes) or behavioral reasons (individuals engages in high levels of physical activity). The 5 & 2 & 2 Plan consists of 5 Medifast meal replacements, 2 Lean & Green meals, and 2 healthy snacks and provides 1,200-1,400 kcal, \>72g protein, \>100g of carbohydrate, and \<30% of calories from fat. The Lean & Green meal is consumer selected and consists of 5-7 ounces of a lean protein, 1 ½ - 3 cups of non-starchy vegetables, and up to 2 healthy fat servings. The healthy snack(s) included in this plans consists of a consumer selected serving of grain/starch, dairy, or fruit.
62
4 & 2 & 1 Plan
MWCC members who used the Medifast 4 & 2 & 1 Meal Replacement Plan for weight loss. 4 & 2 & 1 Plan: Medifast has developed the 4 & 2 & 1 Plan as a higher calorie and higher carbohydrate alternative. This plan may be selected for very obese (BMI ≥ 40kg/m2) or older (\>65 years) individuals, or for medical (e.g., diabetes) or behavioral reasons (individuals engages in high levels of physical activity). The 4 & 2 & 1 Plan consists of 4 Medifast meal replacements, 2 Lean & Green meals, and 1 healthy snack, providing 1,000-1,200 kcal, \>72g protein, \>100g carbohydrate, and \<30% of calories from fat. The Lean & Green meal is consumer selected and consists of 5-7 ounces of a lean protein, 1 ½ - 3 cups of non-starchy vegetables, and up to 2 healthy fat servings. The healthy snack included in this plans consist of a consumer selected serving of grain/starch, dairy, or fruit.
310
Total372

Baseline characteristics

Characteristic5 & 2 & 2 Plan4 & 2 & 1 PlanTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
7 Participants88 Participants95 Participants
Age, Categorical
Between 18 and 65 years
55 Participants222 Participants277 Participants
Age, Continuous46.8 years
STANDARD_DEVIATION 13.7
53.5 years
STANDARD_DEVIATION 14.7
52.4 years
STANDARD_DEVIATION 14.8
BMI48.7 kg/m2
STANDARD_DEVIATION 9.9
37.7 kg/m2
STANDARD_DEVIATION 6.8
39.5 kg/m2
STANDARD_DEVIATION 8.5
Body Fat Mass152.46 Pounds
STANDARD_DEVIATION 41.36
103.40 Pounds
STANDARD_DEVIATION 30.58
110.04 Pounds
STANDARD_DEVIATION 36.41
Lean Body Mass168.52 Pounds
STANDARD_DEVIATION 31.46
135.96 Pounds
STANDARD_DEVIATION 31.24
140.33 Pounds
STANDARD_DEVIATION 33.09
Region of Enrollment
United States
62 participants310 participants372 participants
Sex: Female, Male
Female
27 Participants177 Participants204 Participants
Sex: Female, Male
Male
35 Participants133 Participants168 Participants
Weight327.11 Pounds
STANDARD_DEVIATION 64.33
240.00 Pounds
STANDARD_DEVIATION 47.83
254.02 Pounds
STANDARD_DEVIATION 60.25

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 620 / 310
other
Total, other adverse events
46 / 62219 / 310
serious
Total, serious adverse events
2 / 629 / 310

Outcome results

Primary

Body Weight

The primary endpoint in this study is weight and the primary outcome is change from baseline body weight at 12 weeks for each plan (5 & 2 & 2 and 4 & 2 & 1 Plans). Change from baseline will also be examined at other predetermined time points (e.g., 1, 2, 4, 8, 16, 20 and 24 weeks, and final weight loss visit - the mean length of time from baseline to the final weight loss visit was 18.06 weeks for the 5 & 2 & 2 Plan and 17.35 weeks for the 4 & 2 & 1 Plan.).

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanBody Weight-28.35 PoundsStandard Deviation 15.6
4 & 2 & 1 PlanBody Weight-23.95 PoundsStandard Deviation 12.28
p-value: <0.0001Wilcoxon (Mann-Whitney)
Secondary

Abdominal Circumference

Abdominal circumference expressed as an absolute change from baseline.

Time frame: 20 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanAbdominal Circumference-6.25 InchesStandard Deviation 1.89
4 & 2 & 1 PlanAbdominal Circumference-5.78 InchesStandard Deviation 3.06
Secondary

Abdominal Circumference

Abdominal circumference expressed as an absolute change from baseline.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanAbdominal Circumference-4.42 InchesStandard Deviation 3.04
4 & 2 & 1 PlanAbdominal Circumference-3.28 InchesStandard Deviation 1.99
Secondary

Abdominal Circumference

Abdominal circumference expressed as an absolute change from baseline.

Time frame: 16 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanAbdominal Circumference-5.71 InchesStandard Deviation 1.19
4 & 2 & 1 PlanAbdominal Circumference-4.46 InchesStandard Deviation 2.73
Secondary

Abdominal Circumference

Abdominal circumference expressed as an absolute change from baseline.

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanAbdominal Circumference-2.81 InchesStandard Deviation 2.08
4 & 2 & 1 PlanAbdominal Circumference-1.86 InchesStandard Deviation 1.71
Secondary

Abdominal Circumference

Abdominal circumference expressed as an absolute change from baseline.

Time frame: 12 weeks

Population: Not all subjects remaining at 12 weeks had measurement performed.

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanAbdominal Circumference-3.70 InchesStandard Deviation 1.3
4 & 2 & 1 PlanAbdominal Circumference-4.47 InchesStandard Deviation 2.59
Secondary

Abdominal Circumference

Abdominal circumference expressed as an absolute change from baseline.

Time frame: 24 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanAbdominal Circumference-4.83 InchesStandard Deviation 5.16
4 & 2 & 1 PlanAbdominal Circumference-5.98 InchesStandard Deviation 2.74
Secondary

Adherence

Adherence will be assessed through documented use of meal replacements at each visit.

Time frame: 24 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanAdherence90.67 Percent compliance meal replacementsStandard Deviation 14.86
4 & 2 & 1 PlanAdherence91.22 Percent compliance meal replacementsStandard Deviation 23.47
Secondary

Adherence

Adherence will be assessed through documented use of meal replacements at each visit from baseline (The mean length of time from baseline to the final weight loss visit was 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan.).

Time frame: Baseline to final weight loss visit (Average of 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan)

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanAdherence82.41 Percent compliance meal replacementsStandard Deviation 27.49
4 & 2 & 1 PlanAdherence85.26 Percent compliance meal replacementsStandard Deviation 29.43
Secondary

Adherence

Adherence will be assessed through documented use of meal replacements at each visit.

Time frame: 20 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanAdherence89.00 Percent compliance meal replacementsStandard Deviation 18.04
4 & 2 & 1 PlanAdherence89.25 Percent compliance meal replacementsStandard Deviation 26.79
Secondary

Adherence

Adherence will be assessed through attendance at weekly visits and documented use of meal replacements at each visit. (Meal replacement adherence=average number of self-reported daily meal replacements through 12 weeks/nuber of prescribed meal replacements; Attendance adherence=number of visits/number of weeks on plan

Time frame: 12 weeks

ArmMeasureGroupValue (MEAN)Dispersion
5 & 2 & 2 PlanAdherenceMeal replacement compliance83.85 Percent CompliantStandard Deviation 16.67
5 & 2 & 2 PlanAdherenceAttendance compliance83.65 Percent CompliantStandard Deviation 19.09
4 & 2 & 1 PlanAdherenceMeal replacement compliance88.79 Percent CompliantStandard Deviation 18.64
4 & 2 & 1 PlanAdherenceAttendance compliance85.71 Percent CompliantStandard Deviation 17.94
Secondary

Adherence

Adherence will be assessed through documented use of meal replacements at each visit.

Time frame: 16 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanAdherence79.52 Percent compliance meal replacementsStandard Deviation 26.55
4 & 2 & 1 PlanAdherence94.29 Percent compliance meal replacementsStandard Deviation 17.19
Secondary

Adherence

Adherence will be assessed through documented use of meal replacements at each visit.

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanAdherence94.53 Percent compliance meal replacementsStandard Deviation 13.09
4 & 2 & 1 PlanAdherence96.29 Percent compliance meal replacementsStandard Deviation 14.45
Secondary

Adherence

Adherence will be assessed through documented use of meal replacements at each visit.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanAdherence88.3 Percent compliance meal replacementsStandard Deviation 20.99
4 & 2 & 1 PlanAdherence95.17 Percent compliance meal replacementsStandard Deviation 14.97
Secondary

Blood Pressure

Blood pressure (systolic and diastolic) expressed as an absolute change from baseline.

Time frame: 20 weeks

Population: Not all subjects were remaining at 20 weeks and not all had measurement performed.

ArmMeasureGroupValue (MEAN)Dispersion
5 & 2 & 2 PlanBlood PressureSystolic-21.55 mmHgStandard Deviation 20.62
5 & 2 & 2 PlanBlood PressureDiastolic-8.55 mmHgStandard Deviation 11.12
4 & 2 & 1 PlanBlood PressureSystolic-9.34 mmHgStandard Deviation 17.49
4 & 2 & 1 PlanBlood PressureDiastolic-6.26 mmHgStandard Deviation 13.05
Secondary

Blood Pressure

Blood pressure (systolic and diastolic) expressed as an absolute change from baseline.

Time frame: 1 weeks

ArmMeasureGroupValue (MEAN)Dispersion
5 & 2 & 2 PlanBlood PressureSystolic-4.63 mmHgStandard Deviation 17.17
5 & 2 & 2 PlanBlood PressureDiastolic-2.63 mmHgStandard Deviation 10.49
4 & 2 & 1 PlanBlood PressureSystolic-5.80 mmHgStandard Deviation 14.05
4 & 2 & 1 PlanBlood PressureDiastolic-3.59 mmHgStandard Deviation 9.98
Secondary

Blood Pressure

Blood pressure (systolic and diastolic) expressed as an absolute change from baseline.

Time frame: 2 weeks

Population: Not all subjects were remaining at 2 weeks and not all had measurement performed.

ArmMeasureGroupValue (MEAN)Dispersion
5 & 2 & 2 PlanBlood PressureDiastolic-2.91 mmHgStandard Deviation 9.89
5 & 2 & 2 PlanBlood PressureSystolic-6.41 mmHgStandard Deviation 15.63
4 & 2 & 1 PlanBlood PressureDiastolic-5.37 mmHgStandard Deviation 10.84
4 & 2 & 1 PlanBlood PressureSystolic-8.53 mmHgStandard Deviation 13.97
Secondary

Blood Pressure

Blood pressure (systolic and diastolic) expressed as an absolute change from baseline.

Time frame: 12 weeks

Population: Not all subjects were remaining at 12 weeks and not all had measurement performed.

ArmMeasureGroupValue (MEAN)Dispersion
5 & 2 & 2 PlanBlood PressureSystolic-17.69 mmHgStandard Deviation 17.61
5 & 2 & 2 PlanBlood PressureDiastolic-8.38 mmHgStandard Deviation 8.01
4 & 2 & 1 PlanBlood PressureSystolic-11.27 mmHgStandard Deviation 16.65
4 & 2 & 1 PlanBlood PressureDiastolic-6.60 mmHgStandard Deviation 12.62
Secondary

Blood Pressure

Blood pressure (systolic and diastolic) expressed as an absolute change from baseline.

Time frame: 4 weeks

Population: Not all subjects were remaining at 4 weeks and not all had measurement performed.

ArmMeasureGroupValue (MEAN)Dispersion
5 & 2 & 2 PlanBlood PressureSystolic-7.81 mmHgStandard Deviation 19.76
5 & 2 & 2 PlanBlood PressureDiastolic-7.31 mmHgStandard Deviation 9
4 & 2 & 1 PlanBlood PressureSystolic-9.87 mmHgStandard Deviation 16.93
4 & 2 & 1 PlanBlood PressureDiastolic-5.90 mmHgStandard Deviation 12.13
Secondary

Blood Pressure

Blood pressure (systolic and diastolic) expressed as an absolute change from baseline.

Time frame: 8 weeks

Population: Not all subjects were remaining at 8 weeks and not all had measurement performed.

ArmMeasureGroupValue (MEAN)Dispersion
5 & 2 & 2 PlanBlood PressureSystolic-14.21 mmHgStandard Deviation 26.06
5 & 2 & 2 PlanBlood PressureDiastolic-9.25 mmHgStandard Deviation 11.3
4 & 2 & 1 PlanBlood PressureSystolic-7.51 mmHgStandard Deviation 14.68
4 & 2 & 1 PlanBlood PressureDiastolic-6.11 mmHgStandard Deviation 11.09
Secondary

Blood Pressure

Blood pressure (systolic and diastolic) expressed as an absolute change from baseline to final weight loss visit (The mean length of time from baseline to the final weight loss visit was 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan.).

Time frame: Baseline to final weight loss visit (Average of 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan)

Population: Not all subjects had measurement performed at their final visit.

ArmMeasureGroupValue (MEAN)Dispersion
5 & 2 & 2 PlanBlood PressureSystolic-16.96 mmHgStandard Deviation 21.79
5 & 2 & 2 PlanBlood PressureDiastolic-7.08 mmHgStandard Deviation 10.68
4 & 2 & 1 PlanBlood PressureSystolic-9.52 mmHgStandard Deviation 15.62
4 & 2 & 1 PlanBlood PressureDiastolic-5.64 mmHgStandard Deviation 11.58
Secondary

Blood Pressure

Blood pressure (systolic and diastolic) expressed as an absolute change from baseline.

Time frame: 24 weeks

Population: Not all subjects were remaining at 24 weeks and not all had measurement performed.

ArmMeasureGroupValue (MEAN)Dispersion
5 & 2 & 2 PlanBlood PressureSystolic-14.33 mmHgStandard Deviation 16.19
5 & 2 & 2 PlanBlood PressureDiastolic-5.44 mmHgStandard Deviation 8.41
4 & 2 & 1 PlanBlood PressureSystolic-7.79 mmHgStandard Deviation 19.4
4 & 2 & 1 PlanBlood PressureDiastolic-3.92 mmHgStandard Deviation 14.18
Secondary

Blood Pressure

Blood pressure (systolic and diastolic) expressed as an absolute change from baseline.

Time frame: 16 weeks

Population: Not all subjects were remaining at 16 weeks and not all had measurement performed.

ArmMeasureGroupValue (MEAN)Dispersion
5 & 2 & 2 PlanBlood PressureSystolic-19.27 mmHgStandard Deviation 25.09
5 & 2 & 2 PlanBlood PressureDiastolic-8.55 mmHgStandard Deviation 11.6
4 & 2 & 1 PlanBlood PressureSystolic-10.59 mmHgStandard Deviation 17.03
4 & 2 & 1 PlanBlood PressureDiastolic-6.84 mmHgStandard Deviation 9.94
Secondary

Blood Pressure Categorical

Blood pressure expressed as a categorical variable (normotensive, pre-hypertensive and hypertensive based on National Institute of Health Guidelines) with the percent of participants that improved (e.g. from hypertensive to pre-hypertensive or normal) their blood pressure category from baseline to 12 weeks.

Time frame: 12 weeks

Population: Not all subjects were remaining at 12 weeks and not all had measurement performed.

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanBlood Pressure Categorical53.8 Percent of participants
4 & 2 & 1 PlanBlood Pressure Categorical49.1 Percent of participants
Secondary

Body Weight

Change in body weight from baseline reported as absolute change.

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanBody Weight-7.64 PoundsStandard Deviation 4.86
4 & 2 & 1 PlanBody Weight-5.95 PoundsStandard Deviation 3.33
Secondary

Body Weight

Change in body weight from baseline reported as absolute change.

Time frame: 20 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanBody Weight-40.51 PoundsStandard Deviation 19.08
4 & 2 & 1 PlanBody Weight-32.42 PoundsStandard Deviation 16.22
Secondary

Body Weight

Change in body weight from baseline reported as absolute change from baseline.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanBody Weight-9.71 PoundsStandard Deviation 4.95
4 & 2 & 1 PlanBody Weight-8.24 PoundsStandard Deviation 4.27
Secondary

Body Weight

Change in body weight from baseline to final weight loss visit reported as absolute change. (The mean length of time from baseline to the final weight loss visit was 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan.)

Time frame: Baseline to final weight loss visit (Average of 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan)

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanBody Weight-29.25 PoundsStandard Deviation 27.65
4 & 2 & 1 PlanBody Weight-23.34 PoundsStandard Deviation 18.65
Secondary

Body Weight

Change in body weight from baseline reported as absolute change.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanBody Weight-22.81 PoundStandard Deviation 11.21
4 & 2 & 1 PlanBody Weight-18.32 PoundStandard Deviation 9.21
Secondary

Body Weight

Change in body weight from baseline reported as absolute change.

Time frame: 16 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanBody Weight-36.89 PoundsStandard Deviation 16.45
4 & 2 & 1 PlanBody Weight-28.84 PoundsStandard Deviation 14.48
Secondary

Body Weight

Change in body weight from baseline reported absolute change from baseline.

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanBody Weight-14.26 PoundsStandard Deviation 6.88
4 & 2 & 1 PlanBody Weight-12.25 PoundsStandard Deviation 6.01
Secondary

Fat Mass

Fat mass expressed as an absolute change from baseline.

Time frame: 20 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanFat Mass-34.03 PoundsStandard Deviation 11.64
4 & 2 & 1 PlanFat Mass-29.03 PoundsStandard Deviation 17
Secondary

Fat Mass

Fat mass expressed as an absolute change from baseline.

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanFat Mass-11.46 PoundsStandard Deviation 6.92
4 & 2 & 1 PlanFat Mass-9.09 PoundsStandard Deviation 7.71
Secondary

Fat Mass

Fat mass expressed as an absolute change from baseline.

Time frame: 24 weeks

Population: Not all subjects remaining at 24 weeks had body composition testing performed.

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanFat Mass-56.88 PoundsStandard Deviation 18.52
4 & 2 & 1 PlanFat Mass-32.00 PoundsStandard Deviation 15.76
Secondary

Fat Mass

Fat mass expressed as an absolute change from baseline.

Time frame: 16 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanFat Mass-26.38 PoundsStandard Deviation 9.11
4 & 2 & 1 PlanFat Mass-26.34 PoundsStandard Deviation 12.16
Secondary

Fat Mass

Fat mass expressed as an absolute change from baseline.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanFat Mass-17.35 PoundsStandard Deviation 5.8
4 & 2 & 1 PlanFat Mass-16.27 PoundsStandard Deviation 8.16
Secondary

Fat Mass

Fat mass expressed as an absolute change from baseline.

Time frame: 12 weeks

Population: Not all subjects remaining at 12 weeks had body composition testing performed.

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanFat Mass-21.09 PoundsStandard Deviation 8.09
4 & 2 & 1 PlanFat Mass-21.25 PoundsStandard Deviation 10.9
Secondary

Hip Circumference

Hip circumference expressed as an absolute change from baseline.

Time frame: 24 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanHip Circumference-5.17 InchesStandard Deviation 3.33
4 & 2 & 1 PlanHip Circumference-4.92 InchesStandard Deviation 2.68
Secondary

Hip Circumference

Hip circumference expressed as an absolute change from baseline.

Time frame: 16 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanHip Circumference-4.42 InchesStandard Deviation 3.02
4 & 2 & 1 PlanHip Circumference-3.97 InchesStandard Deviation 2.15
Secondary

Hip Circumference

Hip circumference expressed as an absolute change from baseline.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanHip Circumference-3.34 InchesStandard Deviation 1.99
4 & 2 & 1 PlanHip Circumference-2.68 InchesStandard Deviation 1.64
Secondary

Hip Circumference

Hip circumference expressed as an absolute change from baseline.

Time frame: 12 weeks

Population: Not all subjects remaining at 12 weeks had measurement performed.

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanHip Circumference-4.18 InchesStandard Deviation 2.96
4 & 2 & 1 PlanHip Circumference-3.41 InchesStandard Deviation 2.22
Secondary

Hip Circumference

Hip circumference expressed as an absolute change from baseline.

Time frame: 20 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanHip Circumference-5.38 InchesStandard Deviation 1.9
4 & 2 & 1 PlanHip Circumference-5.38 InchesStandard Deviation 3.96
Secondary

Hip Circumference

Hip circumference expressed as an absolute change from baseline.

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanHip Circumference-2.40 InchesStandard Deviation 1.88
4 & 2 & 1 PlanHip Circumference-1.56 InchesStandard Deviation 1.36
Secondary

Lean Mass

Lean mass expressed as an absolute change from baseline.

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanLean Mass-5.19 PoundsStandard Deviation 5.42
4 & 2 & 1 PlanLean Mass-4.50 PoundsStandard Deviation 4.66
Secondary

Lean Mass

Lean mass expressed as an absolute change from baseline.

Time frame: 12 weeks

Population: Not all subjects remaining at 12 weeks had body composition testing performed.

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanLean Mass-5.47 PoundsStandard Deviation 6.41
4 & 2 & 1 PlanLean Mass-5.31 PoundsStandard Deviation 4.89
Secondary

Lean Mass

Lean mass expressed as an absolute change from baseline.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanLean Mass-8.36 PoundsStandard Deviation 5.67
4 & 2 & 1 PlanLean Mass-4.49 PoundsStandard Deviation 5.36
Secondary

Lean Mass

Lean mass expressed as an absolute change from baseline.

Time frame: 16 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanLean Mass-11.15 PoundsStandard Deviation 4.62
4 & 2 & 1 PlanLean Mass-4.29 PoundsStandard Deviation 6.45
Secondary

Lean Mass

Lean mass expressed as an absolute change from baseline.

Time frame: 20 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanLean Mass-13.83 PoundsStandard Deviation 5.33
4 & 2 & 1 PlanLean Mass-5.08 PoundsStandard Deviation 6.96
Secondary

Lean Mass

Lean mass expressed as an absolute change from baseline.

Time frame: 24 weeks

Population: Not all subjects were remaining at 24 weeks and not all had measurement performed.

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanLean Mass-14.35 PoundsStandard Deviation 9.14
4 & 2 & 1 PlanLean Mass-6.79 PoundsStandard Deviation 6.45
Secondary

Percentage of Subjects Who Lose at Least 5% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 5% of baseline body weight while on each plan (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 12 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanPercentage of Subjects Who Lose at Least 5% of Baseline Body Weight75.7 percentage of subjects
4 & 2 & 1 PlanPercentage of Subjects Who Lose at Least 5% of Baseline Body Weight85.4 percentage of subjects
Secondary

Proportion of Subjects Who Lose at Least 10% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 10% of baseline body weight while on each program (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 2 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight0.0 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight0.0 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 10% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 10% of baseline body weight while on each program (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 1 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight0.0 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight0.0 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 10% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 10% of baseline body weight while on each program (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 8 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight16.7 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight23.0 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 10% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 10% of baseline body weight while on each program (5 & 2 & 2 and 4 & 2 & 1 Plans) at their final weight loss visit (The mean length of time from baseline to the final weight loss visit was 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan.).

Time frame: Baseline to final weight loss visit (Average of 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan)

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight29.0 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight39.9 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 10% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 10% of baseline body weight while on each program (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 24 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight58.8 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight75.3 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 10% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 10% of baseline body weight while on each program (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 20 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight56.5 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight69.6 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 10% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 10% of baseline body weight while on each program (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 16 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight50.0 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight64.9 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 10% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 10% of baseline body weight while on each program (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 4 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight0.0 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight1.0 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 10% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 10% of baseline body weight while on each program (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 12 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight40.5 percentage of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 10% of Baseline Body Weight50.8 percentage of subjects
Secondary

Proportion of Subjects Who Lose at Least 5% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 5% of baseline body weight while on each plan (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 4 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight33.3 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight50.2 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 5% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 5% of baseline body weight while on each plan (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 24 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight88.2 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight96.3 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 5% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 5% of baseline body weight while on each plan (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 20 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight95.7 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight94.6 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 5% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 5% of baseline body weight while on each plan (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 16 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight95.8 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight92.7 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 5% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 5% of baseline body weight while on each plan (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 8 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight72.9 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight76.2 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 5% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 5% of baseline body weight while on each plan (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 1 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight1.6 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight3.2 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 5% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 5% of baseline body weight while on each plan (5 & 2 & 2 and 4 & 2 & 1 Plans).

Time frame: 2 weeks

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight8.9 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight16.1 Percent of subjects
Secondary

Proportion of Subjects Who Lose at Least 5% of Baseline Body Weight

The categorical endpoint of the proportion of subjects who lose at least 5% of baseline body weight while on each plan (5 & 2 & 2 and 4 & 2 & 1 Plans) at their final weight loss visit (The mean length of time from baseline to the final weight loss visit was 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan.).

Time frame: Baseline to final weight loss visit (Average of 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan)

ArmMeasureValue (NUMBER)
5 & 2 & 2 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight62.9 Percent of subjects
4 & 2 & 1 PlanProportion of Subjects Who Lose at Least 5% of Baseline Body Weight69.6 Percent of subjects
Secondary

Pulse

Pulse expressed as an absolute change from baseline.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanPulse-1.17 Beats per minuteStandard Deviation 17.84
4 & 2 & 1 PlanPulse-2.65 Beats per minuteStandard Deviation 10.71
Secondary

Pulse

Pulse expressed as an absolute change from baseline.

Time frame: 1 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanPulse-0.46 Beats per minuteStandard Deviation 12.86
4 & 2 & 1 PlanPulse1.07 Beats per minuteStandard Deviation 9.42
Secondary

Pulse

Pulse expressed as an absolute change from baseline.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanPulse-3.27 mmHgStandard Deviation 10.27
4 & 2 & 1 PlanPulse-1.21 mmHgStandard Deviation 9.94
Secondary

Pulse

Blood pressure (systolic and diastolic) expressed as an absolute change from baseline.

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanPulse-1.62 Beats per minuteStandard Deviation 12.52
4 & 2 & 1 PlanPulse-2.88 Beats per minuteStandard Deviation 10.11
Secondary

Pulse

Pulse expressed as an absolute change from baseline.

Time frame: 16 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanPulse-3.27 Beats per minuteStandard Deviation 11.29
4 & 2 & 1 PlanPulse-3.73 Beats per minuteStandard Deviation 11.89
Secondary

Pulse

Pulse expressed as an absolute change from baseline.

Time frame: 20 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanPulse0.27 Beats per minuteStandard Deviation 13.27
4 & 2 & 1 PlanPulse-2.31 Beats per minuteStandard Deviation 11.78
Secondary

Pulse

Pulse expressed as an absolute change from baseline.

Time frame: 24 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanPulse0.00 Beats per minuteStandard Deviation 4.66
4 & 2 & 1 PlanPulse-3.67 Beats per minuteStandard Deviation 9.34
Secondary

Pulse

Pulse expressed as an absolute change from baseline to final weight loss visit (The mean length of time from baseline to the final weight loss visit was 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan.).

Time frame: Baseline to final weight loss visit (Average of 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan)

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanPulse-2.29 Beats per minuteStandard Deviation 10.75
4 & 2 & 1 PlanPulse-2.29 Beats per minuteStandard Deviation 11.63
Secondary

Pulse

Pulse expressed as an absolute change from baseline.

Time frame: 12 weeks

Population: Not all subjects were remaining at 12 weeks and not all had measurement performed.

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanPulse-3.62 Beats per minuteStandard Deviation 10.04
4 & 2 & 1 PlanPulse-2.95 Beats per minuteStandard Deviation 10.48
Secondary

Resting Metabolic Rate

Resting metabolic rate expressed as an absolute change from baseline to final weight loss visit (The average length of time from baseline to the final weight loss visit was 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan.).

Time frame: Baseline to final weight loss visit (Average of 18 weeks for the 5 & 2 & 2 Plan and 17 weeks for the 4 & 2 & 1 Plan)

Population: Number of participants with paired data at baseline and final weight loss visit was too small for meaningful analysis.

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanResting Metabolic Rate10 caloriesStandard Deviation 0
4 & 2 & 1 PlanResting Metabolic Rate-216.67 caloriesStandard Deviation 279.48
Secondary

Waist Circumference

Waist circumference expressed as an absolute change from baseline.

Time frame: 16 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanWaist Circumference-4.38 InchesStandard Deviation 2.06
4 & 2 & 1 PlanWaist Circumference-4.75 InchesStandard Deviation 2.22
Secondary

Waist Circumference

Waist circumference expressed as an absolute change from baseline.

Time frame: 20 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanWaist Circumference-6.93 InchesStandard Deviation 2.49
4 & 2 & 1 PlanWaist Circumference-5.32 InchesStandard Deviation 2.7
Secondary

Waist Circumference

Waist circumference expressed as an absolute change from baseline.

Time frame: 12 weeks

Population: Not all subjects remaining at 12 weeks had measurement performed.

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanWaist Circumference-3.55 InchesStandard Deviation 1.83
4 & 2 & 1 PlanWaist Circumference-3.87 InchesStandard Deviation 2.34
Secondary

Waist Circumference

Waist circumference expressed as an absolute change from baseline.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanWaist Circumference-3.60 InchesStandard Deviation 2.42
4 & 2 & 1 PlanWaist Circumference-3.24 InchesStandard Deviation 1.72
Secondary

Waist Circumference

Waist circumference expressed as an absolute change from baseline.

Time frame: 24 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanWaist Circumference-3.92 InchesStandard Deviation 3.89
4 & 2 & 1 PlanWaist Circumference-5.35 InchesStandard Deviation 2.88
Secondary

Waist Circumference

Waist circumference expressed as an absolute from baseline.

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
5 & 2 & 2 PlanWaist Circumference-2.21 InchesStandard Deviation 1.49
4 & 2 & 1 PlanWaist Circumference-1.97 InchesStandard Deviation 1.37

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026